Genmab
Stephen Lutsch is a seasoned professional in clinical trial digital innovation, currently serving as Senior Director at Genmab since April 2023, where responsibilities include leading digital innovation efforts and establishing enterprise-level strategies for clinical operations. Prior to this role, Lutsch was Director at LEO Pharma, overseeing the development of future clinical trial setups and managing a global manufacturing IT initiative. At Lundbeck, Lutsch played a key role in RPA and digital strategy, achieving positive ROI for automation projects. Lutsch's career includes positions at IBM Global Services, InnoVentum AB, and CDW, complemented by a strong educational background with a Master's degree from Copenhagen Business School.
This person is not in any teams
This person is not in any offices
Genmab
42 followers
Genmab is a publicly traded, international biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer.